syndrome	score	normalized_score
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	2.00378788	100.0
NEUROBLASTOMA, SUSCEPTIBILITY TO	1.5	74.85822301709901
SACCHAROPINURIA	1.325	66.12476366510411
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	1.3234562699999999	66.04772307535866
DIBASIC AMINO ACIDURIA I	1.291666	64.46121432773613
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	1.111111	55.45053002316792
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	1.10799247	55.294898280350914
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	1.0714286	53.47016072379876
SENGERS SYNDROME	1.05684932	52.74257472801962
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	50.76715106191778
DICARBOXYLICAMINO ACIDURIA	1.0136986	50.58911724728068
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	1.01325343	50.566900823853665
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	1.00347222	50.07876482414895
TEMPI SYNDROME	1.0	49.905482011399336
EHLERS-DANLOS SYNDROME, TYPE I	1.0	49.905482011399336
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	1.0	49.905482011399336
LOCALIZED SCLERODERMA	1.0	49.905482011399336
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0	49.905482011399336
PULMONARY ARTERIOVENOUS MALFORMATION	1.0	49.905482011399336
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	49.905482011399336
BNAR SYNDROME	1.0	49.905482011399336
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	46.57843324214537
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.833333	41.58788504100544
GLUTATHIONE SYNTHETASE DEFICIENCY	0.833333	41.58788504100544
LYSINURIC PROTEIN INTOLERANCE	0.8063719	40.2423783499479
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.75063774	37.46093823064745
HSD10 DISEASE	0.75	37.429111508549504
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.7	34.93383740797953
GLUTARIC ACIDEMIA I; GA1	0.6875378699999999	34.31190880344081
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.67825389	33.848587306556624
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.666667	33.27033797609356
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.6397059	31.92483128503602
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.63545417	31.712646650003695
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.625	31.19092625712458
PRIMARY HYPEROXALURIA TYPE 1	0.6215276999999999	31.017639451936397
BARTH SYNDROME; BTHS	0.6166667	30.77504890387899
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.6121212	30.548203535396173
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.6073995	30.312564820982946
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.60170966	30.02861061321521
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.60170966	30.02861061321521
HAWKINSINURIA	0.5937497	29.631364972623754
HAWKINSINURIA	0.5937497	29.631364972623754
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.5555556	27.725270002132163
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.53678037	26.78828309910728
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.52412562	26.15674170062352
ARGININEMIA	0.5147059	25.686646033611105
MEVALONIC ACIDURIA; MEVA	0.51209291	25.55624350817014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.50666667	25.285444385460597
RECURRENT ACUTE PANCREATITIS	0.5	24.952741005699668
KETOADIPICACIDURIA	0.5	24.952741005699668
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.5	24.952741005699668
HARTNUP DISORDER	0.5	24.952741005699668
UROCANIC ACIDURIA	0.5	24.952741005699668
HARTNUP DISEASE	0.5	24.952741005699668
HYPERTRYPTOPHANEMIA; HYPTRP	0.5	24.952741005699668
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.5	24.952741005699668
RENAL TUBULAR ACIDOSIS III	0.5	24.952741005699668
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	24.952741005699668
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.5	24.952741005699668
GLYCINE ENCEPHALOPATHY	0.5	24.952741005699668
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	24.952741005699668
TRYPTOPHANURIA WITH DWARFISM	0.5	24.952741005699668
THREONINEMIA	0.5	24.952741005699668
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.5	24.952741005699668
CLAPO SYNDROME	0.5	24.952741005699668
%109160 AZOTEMIA, FAMILIAL	0.5	24.952741005699668
RESTRICTIVE DERMOPATHY	0.5	24.952741005699668
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	23.89412096853286
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.45684932	22.799285521180014
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.44049047	21.98288922677784
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.43525371	21.72154619479982
IMINOGLYCINURIA	0.4337661	21.647306300704845
HYPERPROLINEMIA, TYPE II	0.4337661	21.647306300704845
HYPERPROLINEMIA, TYPE I	0.4337661	21.647306300704845
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.4303649	21.477567775287675
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.4303512	21.476884070184116
CYSTINOSIS, NEPHROPATHIC; CTNS	0.42287748	21.10390447116588
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.4199345	20.957033635715973
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.39728456999999995	19.826677961541517
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.383393	19.13341246479642
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.3621212	18.07183303254634
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.3579545	17.863891860649442
KAPOSI SARCOMA	0.35	17.466918703989766
INSULINOMA	0.34920660000000003	17.42732369456192
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.3409091	17.013232957572335
ACUTE ADRENAL INSUFFICIENCY	0.33999967	16.967847415066707
ADDISON DISEASE	0.33999967	16.967847415066707
ADRENOCORTICAL CARCINOMA	0.33954418	16.945115967065334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33712088	16.824180012507114
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.33448279999999997	16.692525358522477
PENTOSURIA	0.333333	16.635144035305775
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.635144035305775
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.333333	16.635144035305775
DISTAL ANOCTAMINOPATHY	0.333333	16.635144035305775
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333333	16.635144035305775
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	16.635144035305775
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.333333	16.635144035305775
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.333333	16.635144035305775
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.3313726	16.53730932837063
DIAMINOPENTANURIA	0.325	16.219281653704783
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.32352939999999997	16.145890651858817
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.32252210000000003	16.09562085982874
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.322282	16.0836385535978
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.3215277	16.0459948485166
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	15.248899499282329
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	14.9716446034198
CONGENITAL ENTEROVIRUS INFECTION	0.29351746	14.648130320061622
PLACENTAL INSUFFICIENCY	0.2934783	14.646176021386056
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2933063	14.637592278480097
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.28740755	14.343212316465353
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	13.86264498216248
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.27352895	13.650594093821947
TYROSINE TRANSAMINASE DEFICIENCY	0.2611111	13.03087530402669
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.25684932	12.81818911890015
MUSCULAR DYSTROPHY, CARDIAC TYPE	0.25347222	12.649653315599455
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	12.607701769311031
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.25230382	12.591343750417336
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	12.533731863873735
BIOTINIDASE DEFICIENCY	0.25	12.476370502849834
CARNOSINEMIA	0.25	12.476370502849834
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	12.476370502849834
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.25	12.476370502849834
CITRULLINEMIA TYPE II	0.25	12.476370502849834
HOMOCARNOSINOSIS	0.25	12.476370502849834
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.25	12.476370502849834
CYSTATHIONINURIA	0.25	12.476370502849834
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.25	12.476370502849834
CARNOSINASE DEFICIENCY	0.25	12.476370502849834
CONGENITAL FACTOR II DEFICIENCY	0.25	12.476370502849834
CYSTATHIONINURIA	0.25	12.476370502849834
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	12.476370502849834
TUBERCULOSIS	0.25	12.476370502849834
WEST SYNDROME	0.25	12.476370502849834
HYPERTRICHOSIS CUBITI	0.25	12.476370502849834
SEVERE HEMOPHILIA A	0.25	12.476370502849834
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	12.476370502849834
HEMOPHILIA B	0.25	12.476370502849834
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.24545450000000002	12.249525134367017
HYPOTONIA-CYSTINURIA SYNDROME	0.24152505000000002	12.053424038077324
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.23863262000000002	11.909075924743092
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.22859747000000002	11.4082669269364
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.22351632	11.154689687014177
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.2208333	11.020792280667953
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.216667	10.812871070963858
2P21 MICRODELETION SYNDROME	0.21370892000000002	10.66524666273558
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.20684932	10.322915018330184
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.20666667000000002	10.313799782040803
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.20549232	10.255193279240714
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.2	9.981096402279867
TRICHOTHIODYSTROPHY	0.2	9.981096402279867
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	9.981096402279867
ROMANO-WARD SYNDROME	0.2	9.981096402279867
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	9.981096402279867
SHOX-RELATED SHORT STATURE	0.2	9.981096402279867
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	9.981096402279867
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.2	9.981096402279867
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.2	9.981096402279867
MEDULLARY SPONGE KIDNEY	0.2	9.981096402279867
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.2	9.981096402279867
HYPOTONIA-CYSTINURIA SYNDROME	0.2	9.981096402279867
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.2	9.981096402279867
HISTIDINEMIA	0.2	9.981096402279867
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	9.981096402279867
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	9.981096402279867
HISTIDINEMIA	0.2	9.981096402279867
HYPERPROLINEMIA TYPE 1	0.2	9.981096402279867
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.19674815	9.818811260601098
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.1964647	9.804665551724966
GITELMAN SYNDROME	0.19545450000000003	9.754251033797052
METHYLMALONIC ACIDURIA, CBLA TYPE	0.1919006	9.576891941276738
METHYLMALONIC ACIDURIA, CBLB TYPE	0.1919006	9.576891941276738
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.18633529999999998	9.299152962238697
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.18036560000000001	9.001232206275247
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.1770837	8.837447404862036
HEREDITARY FRUCTOSE INTOLERANCE	0.1770837	8.837447404862036
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.17370925	8.66904385108867
ETHYLMALONIC ENCEPHALOPATHY	0.17370925	8.66904385108867
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.17045488	8.506632947595232
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.1699345	8.48066313286614
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.1699345	8.48066313286614
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.1699345	8.48066313286614
SLC35A2-CDG	0.1684783	8.40799076996114
VERRUCOUS HEMANGIOMA	0.166667	8.317596970393893
DPM3-CDG	0.166667	8.317596970393893
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.166667	8.317596970393893
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.166667	8.317596970393893
AGEL AMYLOIDOSIS	0.166667	8.317596970393893
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.166667	8.317596970393893
CUTANEOUS NEUROENDOCRINE CARCINOMA	0.166667	8.317596970393893
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.166667	8.317596970393893
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	8.317596970393893
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.166667	8.317596970393893
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1	0.166667	8.317596970393893
PRESSURE-INDUCED LOCALIZED LIPOATROPHY	0.166667	8.317596970393893
ACRODERMATITIS ENTEROPATHICA	0.166667	8.317596970393893
BETA-KETOTHIOLASE DEFICIENCY	0.15938048	7.953959677608191
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.15780204	7.875186868582118
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	7.5487211750177865
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.15000000000000002	7.4858223017099
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.14855374000000002	7.413645999296094
EHLERS-DANLOS SYNDROME, TYPE VI	0.14664487999999998	7.318383420903812
BRUCK SYNDROME 2	0.14285699999999998	7.129347443702473
DE BARSY SYNDROME	0.14285699999999998	7.129347443702473
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.14285699999999998	7.129347443702473
HYPER-BETA-ALANINEMIA	0.14285699999999998	7.129347443702473
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.14285699999999998	7.129347443702473
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	7.129347443702473
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	7.129347443702473
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.14285699999999998	7.129347443702473
CAMPTODACTYLY 1; CAMPD1	0.14285699999999998	7.129347443702473
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.14285699999999998	7.129347443702473
WRINKLY SKIN SYNDROME	0.14285699999999998	7.129347443702473
FAMILIAL EXPANSILE OSTEOLYSIS	0.14285699999999998	7.129347443702473
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	7.129347443702473
CAMPTODACTYLY-TAURINURIA SYNDROME	0.14285699999999998	7.129347443702473
HYPERTAURINURIC CARDIOMYOPATHY	0.14285699999999998	7.129347443702473
GALACTOSEMIA	0.1352263	6.748533682118089
TIGLIC ACIDEMIA	0.1350221	6.7383429826913614
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.13307979	6.6414110659258005
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.13215686999999998	6.59535229846784
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.13151919999999998	6.5635290697536295
PROPIONIC ACIDEMIA	0.12974062	6.474768177557796
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.12509785	6.243068502839733
LYSINE MALABSORPTION SYNDROME	0.125	6.238185251424917
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	6.238185251424917
CENTRAL PRECOCIOUS PUBERTY	0.125	6.238185251424917
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	6.238185251424917
THORACOLARYNGOPELVIC DYSPLASIA	0.125	6.238185251424917
HYDROXYLYSINURIA	0.125	6.238185251424917
PHENYLKETONURIA	0.125	6.238185251424917
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.12480959999999999	6.228683247649946
NEPHROPATHIC INFANTILE CYSTINOSIS	0.12480959999999999	6.228683247649946
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.12152769999999999	6.064898446236734
PRIMARY HYPEROXALURIA	0.12152769999999999	6.064898446236734
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	6.064898446236734
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	6.064898446236734
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12142860000000001	6.059952812969406
PYRUVATE CARBOXYLASE DEFICIENCY	0.12055824000000001	6.016517077645964
OCULOCEREBRORENAL SYNDROME OF LOWE	0.12054792	6.016002053071605
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.11575389	5.776753675144497
SILVER-RUSSELL SYNDROME	0.11554626000000001	5.76639179991447
LOWE OCULOCEREBRORENAL SYNDROME	0.11369860000000001	5.674183437021289
SAY SYNDROME	0.1111111	5.545053002316792
PRIMARY HYPEROXALURIA TYPE 3	0.11111099999999999	5.545048011768591
ENTERIC ANENDOCRINOSIS	0.11111099999999999	5.545048011768591
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	5.545048011768591
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.11111099999999999	5.545048011768591
SARCOIDOSIS	0.11111099999999999	5.545048011768591
RADIO-RENAL SYNDROME	0.11111099999999999	5.545048011768591
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.11111099999999999	5.545048011768591
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.11111099999999999	5.545048011768591
LYMPHANGIOLEIOMYOMATOSIS	0.11111099999999999	5.545048011768591
HENNEKAM SYNDROME	0.11111099999999999	5.545048011768591
FRYNS SYNDROME; FRNS	0.11111099999999999	5.545048011768591
PRIMARY HYPEROXALURIA TYPE 2	0.11111099999999999	5.545048011768591
NEPHROLITHIASIS, CALCIUM OXALATE	0.11111099999999999	5.545048011768591
LYMPHEDEMA, HEREDITARY, III	0.11111099999999999	5.545048011768591
RENAL AGENESIS, BILATERAL	0.11111099999999999	5.545048011768591
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.11111099999999999	5.545048011768591
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.11111099999999999	5.545048011768591
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.1104167	5.510398635608077
FAMILIAL HYPOALDOSTERONISM	0.1104167	5.510398635608077
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	5.510398635608077
RIBOFLAVIN DEFICIENCY	0.10799247000000001	5.3894162689515825
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10666667	5.323251580900869
POLAND SYNDROME	0.10621118	5.300520132899496
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.10621118	5.300520132899496
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.10461802	5.221012715178216
GLYCOGEN STORAGE DISEASE 0, LIVER	0.10383212	5.181791996865457
MAPLE SYRUP URINE DISEASE; MSUD	0.10120892000000001	5.050879936453154
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	4.990548201139934
X-LINKED ACROGIGANTISM	0.1	4.990548201139934
SAGLIKER SYNDROME	0.1	4.990548201139934
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	4.990548201139934
NAGER SYNDROME	0.1	4.990548201139934
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	4.990548201139934
GLOMUVENOUS MALFORMATION	0.1	4.990548201139934
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	4.990548201139934
RABSON-MENDENHALL SYNDROME	0.1	4.990548201139934
TRISOMY 18	0.1	4.990548201139934
METAPHYSEAL ANADYSPLASIA	0.1	4.990548201139934
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	4.990548201139934
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.09989778	4.985446862768728
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.09931246	4.956236186037816
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.09704222000000001	4.842938764556258
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.09460756	4.721435883722382
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.09330630000000001	4.65649587620023
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.09330630000000001	4.65649587620023
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.09280117	4.6312871200718115
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.09178929999999999	4.580789259988936
DILATED CARDIOMYOPATHY WITH ATAXIA	0.09133212	4.557973471722965
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.09133212	4.557973471722965
INCONTINENTIA PIGMENTI	0.0909091	4.536862454722503
GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS	0.0909091	4.536862454722503
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0909091	4.536862454722503
PROGRESSIVE HEMIFACIAL ATROPHY	0.0909091	4.536862454722503
GLUCOGLYCINURIA	0.0909091	4.536862454722503
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.0909091	4.536862454722503
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0909091	4.536862454722503
PAGOD SYNDROME	0.0909091	4.536862454722503
GLYCINE ENCEPHALOPATHY; GCE	0.0909091	4.536862454722503
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.0909091	4.536862454722503
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0909091	4.536862454722503
LINEAR NEVUS SEBACEUS SYNDROME	0.0909091	4.536862454722503
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.0909091	4.536862454722503
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.0909091	4.536862454722503
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	4.493409751535178
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.08999997000000001	4.49149188386148
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.08803927	4.393642205281729
PROPIONIC ACIDEMIA	0.08803927	4.393642205281729
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.08765341	4.37438567599281
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.08722494	4.353002674115386
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.08700083	4.341818356541811
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.08662562	4.323093320636314
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.08526413999999999	4.255148004987434
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0844828	4.216154855672647
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0844828	4.216154855672647
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0844828	4.216154855672647
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0844828	4.216154855672647
GLYCEROL KINASE DEFICIENCY; GKD	0.08375007	4.179587611838435
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.08333330000000001	4.158788504100545
TYROSINEMIA TYPE 1	0.08333330000000001	4.158788504100545
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.08333330000000001	4.158788504100545
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08333330000000001	4.158788504100545
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.08333330000000001	4.158788504100545
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.08313428	4.148856315070636
NEUTRAL LIPID STORAGE MYOPATHY	0.08313428	4.148856315070636
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.08303657	4.143980050423302
HEMOCHROMATOSIS, TYPE 1	0.08217498000000001	4.100981986177101
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.08137259999999999	4.060938825520792
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0803653	4.010669033490711
TEMPLE SYNDROME	0.07983196000000001	3.9840524437147513
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.07958337	3.9716464399415368
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.07859747	3.922444625226499
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.07859482000000001	3.922312375699169
274210 THYMIC APLASIA WITH FETAL DEATH	0.0776316	3.8742424173161485
AMISH LETHAL MICROCEPHALY	0.0770834	3.846884232077499
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.07692310000000001	3.8388843833110724
MARINESCO-SJÖGREN SYNDROME	0.07692310000000001	3.8388843833110724
DISTAL MYOPATHY, TATEYAMA TYPE	0.07692310000000001	3.8388843833110724
WALKER-WARBURG SYNDROME	0.07692310000000001	3.8388843833110724
ADULT-ONSET DYSTONIA-PARKINSONISM	0.07692310000000001	3.8388843833110724
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.07692310000000001	3.8388843833110724
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.07692310000000001	3.8388843833110724
FAMILIAL DILATED CARDIOMYOPATHY	0.07692310000000001	3.8388843833110724
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.07692310000000001	3.8388843833110724
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.07692310000000001	3.8388843833110724
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.07692310000000001	3.8388843833110724
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.07599432	3.7925331697285243
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.07537785	3.761767937232957
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.07370895	3.6784806783041324
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0734649	3.6663012454192505
WOLCOTT-RALLISON SYNDROME	0.07333337	3.659737177370291
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.07287787999999999	3.637005729368919
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.07287787999999999	3.637005729368919
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.07287787999999999	3.637005729368919
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0725221	3.6192503569789034
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0725221	3.6192503569789034
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07142860000000001	3.5646787123994392
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07142860000000001	3.5646787123994392
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07142860000000001	3.5646787123994392
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07142860000000001	3.5646787123994392
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	3.5646787123994392
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.07013892	3.5003166103589765
XP21 MICRODELETION SYNDROME	0.07013892	3.5003166103589765
KNIEST-LIKE DYSPLASIA, LETHAL	0.06965565	3.476198788067328
GLYCOGEN STORAGE DISEASE IXC	0.06954225	3.4705395064072353
GLYCOGEN STORAGE DISEASE IXA	0.06916667	3.451796005473394
SHORT STATURE DUE TO GHSR DEFICIENCY	0.06916667	3.451796005473394
ALKAPTONURIA	0.06878788	3.432892307942296
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0685046	3.4187550829981066
KEUTEL SYNDROME; KTLS	0.0684783	3.4174425688212073
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.06817812	3.402461941231025
HYDROXYKYNURENINURIA	0.0675936	3.373291188885722
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.06720265	3.3537806406933655
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0666667	3.3270337976093556
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0666667	3.3270337976093556
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0663302	3.31024060291252
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.06619535	3.3035108486632825
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0647059	3.229179128481404
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0643116	3.209501396924309
LASSA FEVER	0.0638865	3.1882865765212633
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.0637427	3.1811101682080243
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.06370892	3.1794243610256787
WILLIAMS-BEUREN SYNDROME; WBS	0.06176678000000001	3.08250092819206
SECKEL SYNDROME 10; SCKL10	0.06176678000000001	3.08250092819206
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.06176678000000001	3.08250092819206
LETHAL KNIEST-LIKE DYSPLASIA	0.06125229	3.056825056752015
EMANUEL SYNDROME	0.06103496	3.0459790983464776
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	3.0459790983464776
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	3.0459790983464776
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.06103496	3.0459790983464776
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.060416700000000004	3.0151245350381104
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0601604	3.0023337599985886
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.05934607	2.9616942288322456
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.05934607	2.9616942288322456
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.05916342	2.9525789925428634
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.9356151210975487
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.9356151210975487
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0588235	2.9356151210975487
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0588235	2.9356151210975487
ACQUIRED METHEMOGLOBINEMIA	0.0588235	2.9356151210975487
VICI SYNDROME; VICIS	0.0588235	2.9356151210975487
TRANSCOBALAMIN DEFICIENCY	0.0588235	2.9356151210975487
KEARNS-SAYRE SYNDROME; KSS	0.058707930000000005	2.9298475445414915
SÉZARY SYNDROME	0.05862069	2.9254937902908167
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05840336	2.9146478318852793
MICROFORM HOLOPROSENCEPHALY	0.05840336	2.9146478318852793
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.05840336	2.9146478318852793
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.05684932	2.837092716620284
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.05684932	2.837092716620284
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.05684932	2.837092716620284
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.05684932	2.837092716620284
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.05666667	2.8279774803309023
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.05641948	2.815641344232504
PYGMY	0.05641948	2.815641344232504
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.05641948	2.815641344232504
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0558712	2.788279166555294
HYDROXYKYNURENINURIA	0.0558712	2.788279166555294
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0558712	2.788279166555294
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.055555600000000004	2.772528996432497
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.055555600000000004	2.772528996432497
ESTROGEN RESISTANCE; ESTRR	0.055555600000000004	2.772528996432497
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.055555600000000004	2.772528996432497
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.772528996432497
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.772528996432497
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	2.772528996432497
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.055555600000000004	2.772528996432497
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.772528996432497
ANIRIDIA	0.055555600000000004	2.772528996432497
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.055555600000000004	2.772528996432497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.772528996432497
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.055555600000000004	2.772528996432497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.772528996432497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.772528996432497
OBESITY DUE TO SIM1 DEFICIENCY	0.055555600000000004	2.772528996432497
HEMOCHROMATOSIS, TYPE 4; HFE4	0.055555600000000004	2.772528996432497
X-LINKED SIDEROBLASTIC ANEMIA	0.055555600000000004	2.772528996432497
ESTROGEN RESISTANCE SYNDROME	0.055555600000000004	2.772528996432497
HYPERLIPOPROTEINEMIA, TYPE IV	0.055555600000000004	2.772528996432497
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.05522876	2.756217888691891
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	2.7243103197130827
HYPOPLASMINOGENEMIA	0.0545894	2.7243103197130827
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	2.626605367031165
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	2.626605367031165
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0526316	2.626605367031165
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	2.626605367031165
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	2.626605367031165
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0526316	2.626605367031165
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	2.626605367031165
STEINERT MYOTONIC DYSTROPHY	0.0526316	2.626605367031165
15Q OVERGROWTH SYNDROME	0.0526316	2.626605367031165
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	2.626605367031165
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	2.626605367031165
MEIER-GORLIN SYNDROME 1; MGORS1	0.0526316	2.626605367031165
MYASTHENIA GRAVIS; MG	0.0526316	2.626605367031165
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	2.626605367031165
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	2.626605367031165
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	2.626605367031165
BIEMOND SYNDROME II	0.0526316	2.626605367031165
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.05230382	2.610247348137469
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.05212117	2.6011321118480866
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.05188166	2.5891792498515365
CONGENITAL ANALBUMINEMIA	0.05188166	2.5891792498515365
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.05186887	2.58854095873661
PROTEUS SYNDROME	0.0515873	2.574489072166661
FOCAL DERMAL HYPOPLASIA	0.0515873	2.574489072166661
JUVENILE IDIOPATHIC ARTHRITIS	0.05	2.495274100569967
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05	2.495274100569967
HYPOPLASTIC LEFT HEART SYNDROME	0.05	2.495274100569967
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	2.495274100569967
PENILE AGENESIS	0.05	2.495274100569967
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.05	2.495274100569967
THYMOMA	0.05	2.495274100569967
FAMILIAL SPONTANEOUS PNEUMOTHORAX	0.05	2.495274100569967
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.05	2.495274100569967
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	2.495274100569967
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05	2.495274100569967
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.05	2.495274100569967
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.05	2.495274100569967
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	2.495274100569967
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.05	2.495274100569967
RHEUMATIC FEVER	0.05	2.495274100569967
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.05	2.495274100569967
FOIX-CHAVANY-MARIE SYNDROME	0.05	2.495274100569967
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	2.495274100569967
ULBRIGHT-HODES SYNDROME	0.05	2.495274100569967
CAUDAL REGRESSION SEQUENCE	0.05	2.495274100569967
ESOPHAGEAL ATRESIA	0.05	2.495274100569967
STEVENS-JOHNSON SYNDROME	0.05	2.495274100569967
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.05	2.495274100569967
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.05	2.495274100569967
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	2.495274100569967
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.05	2.495274100569967
GIANT CELL ARTERITIS	0.05	2.495274100569967
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.05	2.495274100569967
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.05	2.495274100569967
MUCOPOLYSACCHARIDOSIS TYPE 7	0.05	2.495274100569967
X-LINKED IMMUNONEUROLOGIC DISORDER	0.05	2.495274100569967
FEMORAL-FACIAL SYNDROME	0.05	2.495274100569967
REACTIVE ARTHRITIS	0.05	2.495274100569967
LEGIONELLOSIS	0.05	2.495274100569967
TOXIC EPIDERMAL NECROLYSIS	0.05	2.495274100569967
FAMILIAL DYSAUTONOMIA	0.05	2.495274100569967
PELIZAEUS-MERZBACHER DISEASE	0.04840336	2.415593011771286
PERMANENT NEONATAL DIABETES MELLITUS	0.0454545	2.268428732087151
ALAGILLE SYNDROME 2	0.0454545	2.268428732087151
RICHARDS-RUNDLE SYNDROME; RRNS	0.0454545	2.268428732087151
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0454545	2.268428732087151
ALAGILLE SYNDROME 1; ALGS1	0.0454545	2.268428732087151
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	2.268428732087151
RICHARDS-RUNDLE SYNDROME	0.0454545	2.268428732087151
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	2.268428732087151
TRANSIENT NEONATAL DIABETES MELLITUS	0.0454545	2.268428732087151
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	2.268428732087151
VICI SYNDROME	0.0454545	2.268428732087151
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	2.268428732087151
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.04467354	2.2294545468555285
FAMILIAL MULTIPLE NEVI FLAMMEI	0.044334990000000005	2.2125590459205693
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.044334990000000005	2.2125590459205693
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.04411766	2.201713087515032
VISCERAL STEATOSIS, CONGENITAL	0.04370367	2.1810527170171325
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	2.1698055185362235
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.043478300000000004	2.1698055185362235
ASHERMAN SYNDROME	0.043478300000000004	2.1698055185362235
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	2.1698055185362235
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	2.1698055185362235
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	2.1698055185362235
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	2.1698055185362235
JUVENILE XANTHOGRANULOMA	0.043478300000000004	2.1698055185362235
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	2.1698055185362235
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	2.1698055185362235
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	2.1698055185362235
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	2.1698055185362235
YELLOW FEVER	0.043478300000000004	2.1698055185362235
FAMILIAL THROMBOCYTOSIS	0.043478300000000004	2.1698055185362235
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	2.1698055185362235
LICHTENSTEIN SYNDROME	0.043478300000000004	2.1698055185362235
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	2.1698055185362235
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	2.1698055185362235
NEUROFIBROMATOSIS TYPE 1	0.043478300000000004	2.1698055185362235
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	2.1698055185362235
WERNER SYNDROME	0.043478300000000004	2.1698055185362235
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	2.1698055185362235
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	2.1698055185362235
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	2.1698055185362235
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	2.1698055185362235
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	2.1698055185362235
RHEUMATOID ARTHRITIS	0.043478300000000004	2.1698055185362235
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	2.1698055185362235
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	2.1698055185362235
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	2.1698055185362235
HYDATIDIFORM MOLE	0.043478300000000004	2.1698055185362235
BECKWITH-WIEDEMANN SYNDROME	0.04288616	2.1402544864179935
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.996219280455973
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04	1.996219280455973
SMITH-MAGENIS SYNDROME; SMS	0.04	1.996219280455973
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.996219280455973
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04	1.996219280455973
MECKEL SYNDROME, TYPE 5	0.04	1.996219280455973
TRISOMY 12P	0.04	1.996219280455973
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.996219280455973
3Q13 MICRODELETION SYNDROME	0.04	1.996219280455973
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04	1.996219280455973
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.996219280455973
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.996219280455973
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.996219280455973
KOOLEN-DE VRIES SYNDROME; KDVS	0.04	1.996219280455973
NON-DISTAL TRISOMY 10Q	0.04	1.996219280455973
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.996219280455973
BLACKFAN-DIAMOND ANEMIA	0.04	1.996219280455973
KAPUR-TORIELLO SYNDROME	0.04	1.996219280455973
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.996219280455973
COCAINE EMBRYOFETOPATHY	0.04	1.996219280455973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.03901417	1.9470209591246754
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.03863859	1.928277458190834
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.038253430000000005	1.909055862739324
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.848349337256197
GENITOURINARY TRACT ANOMALIES	0.037037	1.848349337256197
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.848349337256197
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.848349337256197
SCIMITAR SYNDROME	0.037037	1.848349337256197
TESTICULAR TORSION	0.037037	1.848349337256197
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.848349337256197
HYPERLYSINEMIA, TYPE I	0.037037	1.848349337256197
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.848349337256197
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.848349337256197
PEYRONIE DISEASE	0.037037	1.848349337256197
DK PHOCOMELIA SYNDROME	0.037037	1.848349337256197
GALACTORRHEA	0.037037	1.848349337256197
NATHALIE SYNDROME	0.037037	1.848349337256197
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.848349337256197
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.848349337256197
ADENOMYOSIS	0.037037	1.848349337256197
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.848349337256197
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.848349337256197
300270 ADRENOMYODYSTROPHY	0.037037	1.848349337256197
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.848349337256197
URINARY BLADDER, ATONY OF	0.037037	1.848349337256197
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0361111	1.8021418514618426
MARFANOID HYPERMOBILITY SYNDROME	0.0361111	1.8021418514618426
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.035714300000000004	1.7823393561997196
TOWNES-BROCKS SYNDROME	0.035714300000000004	1.7823393561997196
DYSSPONDYLOENCHONDROMATOSIS	0.035714300000000004	1.7823393561997196
MOSAIC TRISOMY 14	0.035714300000000004	1.7823393561997196
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.035714300000000004	1.7823393561997196
BECKER NEVUS SYNDROME	0.035714300000000004	1.7823393561997196
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.035714300000000004	1.7823393561997196
OCULOECTODERMAL SYNDROME; OES	0.035714300000000004	1.7823393561997196
PROTEUS-LIKE SYNDROME	0.035714300000000004	1.7823393561997196
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.035714300000000004	1.7823393561997196
1P36 DELETION SYNDROME	0.035714300000000004	1.7823393561997196
HENNEKAM-BEEMER SYNDROME	0.035714300000000004	1.7823393561997196
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.035714300000000004	1.7823393561997196
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.035714300000000004	1.7823393561997196
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.035714300000000004	1.7823393561997196
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.035714300000000004	1.7823393561997196
FIBULAR HEMIMELIA	0.035714300000000004	1.7823393561997196
49,XYYYY SYNDROME	0.035714300000000004	1.7823393561997196
KLIPPEL-TRÉNAUNAY SYNDROME	0.035714300000000004	1.7823393561997196
MELORHEOSTOSIS	0.035714300000000004	1.7823393561997196
CURRARINO SYNDROME	0.035714300000000004	1.7823393561997196
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.03526414	1.7598739044174676
LYSINURIC PROTEIN INTOLERANCE; LPI	0.03525382	1.75935887984311
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.03507117	1.7502436435537279
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0344828	1.720880755102681
MODY	0.0344828	1.720880755102681
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.0344828	1.720880755102681
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0344828	1.720880755102681
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.720880755102681
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.032336050000000005	1.6137461615947097
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.032336050000000005	1.6137461615947097
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.03206969	1.600453337406153
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.03178927	1.5864588421405164
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03166667	1.580340430045919
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.03121118	1.5576089820445467
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.03121118	1.5576089820445467
FUMARASE DEFICIENCY; FMRD	0.03115755	1.554932551044275
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.031154839999999996	1.5547973071880241
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.03097494	1.5458193109741736
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0308249	1.5383314924531832
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.02999326	1.4968280973932233
ALKAPTONURIA	0.029571599999999996	1.4757849518482964
HOOFT DISEASE	0.028787880000000002	1.4366730274863226
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.0284045	1.4175402637927923
ARGININOSUCCINIC ACIDURIA	0.0284045	1.4175402637927923
ARGININOSUCCINIC ACIDURIA	0.0284045	1.4175402637927923
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.027682619999999998	1.3815144944384032
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.027682619999999998	1.3815144944384032
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.027590169999999997	1.3769007326264493
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.027590169999999997	1.3769007326264493
POEMS SYNDROME	0.026619379999999998	1.3284529897446031
PANCREATITIS, HEREDITARY	0.026619379999999998	1.3284529897446031
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.026576449999999998	1.3263105474018537
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02607964	1.3015170048837705
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.02588671	1.2918887402393113
ZUNICH NEUROECTODERMAL SYNDROME	0.025	1.2476370502849834
ANDROGEN INSENSITIVITY SYNDROME	0.025	1.2476370502849834
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	1.2476370502849834
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	1.2476370502849834
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025	1.2476370502849834
ZIMMERMANN-LABAND SYNDROME 1	0.025	1.2476370502849834
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	1.2476370502849834
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	1.2476370502849834
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	1.2476370502849834
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	1.2476370502849834
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	1.2476370502849834
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	1.2476370502849834
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.025	1.2476370502849834
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	1.2476370502849834
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	1.2476370502849834
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	1.2476370502849834
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	1.2476370502849834
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	1.2476370502849834
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025	1.2476370502849834
CZECH DYSPLASIA, METATARSAL TYPE	0.025	1.2476370502849834
CLASSIC MYCOSIS FUNGOIDES	0.02449369	1.2223694056877916
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	1.213115931213238
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.024213069999999996	1.2083649293257526
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.02412562	1.204000694923856
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.02412562	1.204000694923856
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.02393269	1.1943724302793965
GROWTH HORMONE INSENSITIVITY SYNDROME	0.022539669999999998	1.124853095727877
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.02251226	1.1234851864659448
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.02208418	1.1021216477265048
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.02208418	1.1021216477265048
ERYTHROKERATODERMIA VARIABILIS	0.02208418	1.1021216477265048
JOHANSON-BLIZZARD SYNDROME; JBS	0.02208418	1.1021216477265048
INFANTILE LIVER FAILURE SYNDROME 2	0.02137257	1.0666084076723732
SPLENOPORTAL VASCULAR ANOMALIES	0.020917079999999998	1.0438769596710007
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	1.0396958783880856
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0208333	1.0396958783880856
NEMALINE MYOPATHY 3; NEM3	0.0208333	1.0396958783880856
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0208333	1.0396958783880856
WELANDER DISTAL MYOPATHY; WDM	0.0208333	1.0396958783880856
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0208333	1.0396958783880856
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0208333	1.0396958783880856
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0208333	1.0396958783880856
NEMALINE MYOPATHY 2; NEM2	0.0208333	1.0396958783880856
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.0208333	1.0396958783880856
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.0208333	1.0396958783880856
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.0208333	1.0396958783880856
LAING EARLY-ONSET DISTAL MYOPATHY	0.0208333	1.0396958783880856
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.0208333	1.0396958783880856
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0208333	1.0396958783880856
GNE MYOPATHY	0.0208333	1.0396958783880856
DISTAL MYOPATHY, WELANDER TYPE	0.0208333	1.0396958783880856
TIBIAL MUSCULAR DYSTROPHY	0.0208333	1.0396958783880856
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0208333	1.0396958783880856
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.0208333	1.0396958783880856
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0208333	1.0396958783880856
MYOPATHY, DISTAL, 4; MPD4	0.0208333	1.0396958783880856
MYOPATHY, DISTAL 3	0.0208333	1.0396958783880856
SATOYOSHI SYNDROME	0.0208333	1.0396958783880856
HYPOKALEMIC PERIODIC PARALYSIS	0.0208333	1.0396958783880856
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.0208333	1.0396958783880856
THYROTOXIC PERIODIC PARALYSIS	0.0208333	1.0396958783880856
MYOPATHY, DISTAL, 1; MPD1	0.0208333	1.0396958783880856
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.0208333	1.0396958783880856
ADULT-ONSET NEMALINE MYOPATHY	0.0208333	1.0396958783880856
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0208333	1.0396958783880856
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0208333	1.0396958783880856
MYOPATHIC EHLERS-DANLOS SYNDROME	0.0208333	1.0396958783880856
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.0208333	1.0396958783880856
MYOPATHY, DISTAL, 5; MPD5	0.0208333	1.0396958783880856
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.0208333	1.0396958783880856
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0208333	1.0396958783880856
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.020740849999999998	1.0350821165761317
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.020740849999999998	1.0350821165761317
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.020740849999999998	1.0350821165761317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.020738239999999998	1.0349518632680819
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.02055824	1.0259688765060302
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.02055824	1.0259688765060302
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.02055824	1.0259688765060302
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.02055824	1.0259688765060302
ERDHEIM-CHESTER DISEASE	0.020408199999999998	1.0184810579850399
KAPOSIFORM LYMPHANGIOMATOSIS	0.020408199999999998	1.0184810579850399
AL AMYLOIDOSIS	0.020408199999999998	1.0184810579850399
OVARIAN HYPERSTIMULATION SYNDROME	0.020408199999999998	1.0184810579850399
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.020408199999999998	1.0184810579850399
MALIGNANT ATROPHIC PAPULOSIS	0.020408199999999998	1.0184810579850399
HEMORRHAGIC FEVER-RENAL SYNDROME	0.020408199999999998	1.0184810579850399
MULTIPLE MYELOMA	0.020408199999999998	1.0184810579850399
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.020408199999999998	1.0184810579850399
PRIMARY EFFUSION LYMPHOMA	0.020408199999999998	1.0184810579850399
CHRONIC GRAFT VERSUS HOST DISEASE	0.020408199999999998	1.0184810579850399
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.020408199999999998	1.0184810579850399
PRIMARY SCLEROSING CHOLANGITIS	0.020408199999999998	1.0184810579850399
INTESTINAL LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
PLEURAL MESOTHELIOMA	0.020408199999999998	1.0184810579850399
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.020408199999999998	1.0184810579850399
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.020408199999999998	1.0184810579850399
FOLLICULAR LYMPHOMA	0.020408199999999998	1.0184810579850399
ADENOCARCINOMA OF OVARY	0.020408199999999998	1.0184810579850399
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.020408199999999998	1.0184810579850399
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
BEHÇET DISEASE	0.020408199999999998	1.0184810579850399
CRYPTOCOCCOSIS	0.020408199999999998	1.0184810579850399
KIKUCHI-FUJIMOTO DISEASE	0.020408199999999998	1.0184810579850399
NOONAN SYNDROME 8; NS8	0.020408199999999998	1.0184810579850399
LEPTOSPIROSIS	0.020408199999999998	1.0184810579850399
MEIGE DISEASE	0.020408199999999998	1.0184810579850399
SYSTEMIC CAPILLARY LEAK SYNDROME	0.020408199999999998	1.0184810579850399
RING CHROMOSOME 22 SYNDROME	0.020408199999999998	1.0184810579850399
HELLP SYNDROME	0.020408199999999998	1.0184810579850399
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.020408199999999998	1.0184810579850399
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.020408199999999998	1.0184810579850399
OVARIAN FIBROMA	0.020408199999999998	1.0184810579850399
NOCARDIOSIS	0.020408199999999998	1.0184810579850399
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.020408199999999998	1.0184810579850399
WILD TYPE ATTR AMYLOIDOSIS	0.020408199999999998	1.0184810579850399
OVARIAN FIBROTHECOMA	0.020408199999999998	1.0184810579850399
WALDENSTRÖM MACROGLOBULINEMIA	0.020408199999999998	1.0184810579850399
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020408199999999998	1.0184810579850399
ISOLATED COMPLEX I DEFICIENCY	0.0199201	0.9941221922152759
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.01882006	0.939224165783456
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.01745895	0.8712973151629204
COLCHICINE POISONING	0.01745895	0.8712973151629204
PEARSON SYNDROME	0.01745895	0.8712973151629204
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.017363789999999997	0.8665483094947154
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.017363789999999997	0.8665483094947154
MELAS	0.017363789999999997	0.8665483094947154
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.01726602	0.8616690505184611
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	0.8616690505184611
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01726602	0.8616690505184611
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	0.8616690505184611
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01726602	0.8616690505184611
DENT DISEASE	0.017170819999999996	0.8569180486309758
CINCA SYNDROME	0.01702405	0.8495934210361628
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.01702405	0.8495934210361628
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.01702405	0.8495934210361628
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.015872999999999998	0.7921497159669414
HEREDITARY METHEMOGLOBINEMIA	0.015872999999999998	0.7921497159669414
PSEUDOPELADE OF BROCQ	0.015872999999999998	0.7921497159669414
MOEBIUS SYNDROME; MBS	0.015872999999999998	0.7921497159669414
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.7921497159669414
DERMATOMYOSITIS	0.015872999999999998	0.7921497159669414
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.7921497159669414
ACRODYSOSTOSIS	0.015872999999999998	0.7921497159669414
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.015872999999999998	0.7921497159669414
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.015872999999999998	0.7921497159669414
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.015872999999999998	0.7921497159669414
PILI TORTI	0.015872999999999998	0.7921497159669414
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.015872999999999998	0.7921497159669414
TOE, ROTATED FIFTH	0.015872999999999998	0.7921497159669414
ACROKERATOELASTOIDOSIS OF COSTA	0.015872999999999998	0.7921497159669414
STRIATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.7921497159669414
INTELLECTUAL DISABILITY, WOLFF TYPE	0.015872999999999998	0.7921497159669414
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.015872999999999998	0.7921497159669414
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.015872999999999998	0.7921497159669414
FUCOSIDOSIS	0.015872999999999998	0.7921497159669414
LUNULAE OF FINGERNAILS	0.015872999999999998	0.7921497159669414
TYROSINEMIA TYPE 2	0.015872999999999998	0.7921497159669414
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.015872999999999998	0.7921497159669414
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.7921497159669414
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.015872999999999998	0.7921497159669414
LAMELLAR ICHTHYOSIS	0.015872999999999998	0.7921497159669414
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.015872999999999998	0.7921497159669414
ADNP SYNDROME	0.015872999999999998	0.7921497159669414
PROGEROID SYNDROME, PETTY TYPE	0.015872999999999998	0.7921497159669414
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.015872999999999998	0.7921497159669414
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.7921497159669414
MONILETHRIX	0.015872999999999998	0.7921497159669414
ADACTYLIA, UNILATERAL	0.015872999999999998	0.7921497159669414
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.015872999999999998	0.7921497159669414
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.015872999999999998	0.7921497159669414
SILLENCE SYNDROME	0.015872999999999998	0.7921497159669414
NAILBEDS, PIGMENTATION OF	0.015872999999999998	0.7921497159669414
FLOTCH SYNDROME	0.015872999999999998	0.7921497159669414
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.015872999999999998	0.7921497159669414
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.015872999999999998	0.7921497159669414
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.7921497159669414
NAIL LOW-SULFUR PROTEIN	0.015872999999999998	0.7921497159669414
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.015872999999999998	0.7921497159669414
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.015872999999999998	0.7921497159669414
NAIL HIGH-SULFUR PROTEIN	0.015872999999999998	0.7921497159669414
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.015872999999999998	0.7921497159669414
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.015872999999999998	0.7921497159669414
NASODIGITOACOUSTIC SYNDROME	0.015872999999999998	0.7921497159669414
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.015872999999999998	0.7921497159669414
CHILBLAIN LUPUS 1	0.015872999999999998	0.7921497159669414
LICHEN PLANUS PEMPHIGOIDES	0.015872999999999998	0.7921497159669414
MULTIPLE SYNOSTOSES SYNDROME	0.015872999999999998	0.7921497159669414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.01544561	0.7708206120100897
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.01528736	0.7629230694817857
COSTELLO SYNDROME; CSTLO	0.015070030000000002	0.7520771110762483
KERATOSIS, FAMILIAL ACTINIC	0.014898980000000001	0.7435407783781984
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.014898980000000001	0.7435407783781984
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.014898980000000001	0.7435407783781984
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.014898980000000001	0.7435407783781984
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.014898980000000001	0.7435407783781984
GLOMUVENOUS MALFORMATIONS	0.014898980000000001	0.7435407783781984
PRADER-WILLI SYNDROME	0.01483187	0.7401916214804134
JOHANSON-BLIZZARD SYNDROME	0.01483187	0.7401916214804134
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0147059	0.7339050279114374
PATENT DUCTUS VENOSUS	0.0147059	0.7339050279114374
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0147059	0.7339050279114374
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0147059	0.7339050279114374
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.0147059	0.7339050279114374
CITRULLINEMIA TYPE I	0.0147059	0.7339050279114374
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0147059	0.7339050279114374
GLUTAMINE DEFICIENCY, CONGENITAL	0.0147059	0.7339050279114374
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.0147059	0.7339050279114374
CITRULLINEMIA, CLASSIC	0.0147059	0.7339050279114374
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0147059	0.7339050279114374
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01461454	0.729345663074876
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.013891569999999999	0.6932654967450945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.013891569999999999	0.6932654967450945
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.013891569999999999	0.6932654967450945
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.013891569999999999	0.6932654967450945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.013891569999999999	0.6932654967450945
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.013891569999999999	0.6932654967450945
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.013891569999999999	0.6932654967450945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	0.6932654967450945
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.013891569999999999	0.6932654967450945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013891569999999999	0.6932654967450945
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	0.6932654967450945
LIVER FAILURE, INFANTILE, TRANSIENT	0.013891569999999999	0.6932654967450945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.013891569999999999	0.6932654967450945
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013891569999999999	0.6932654967450945
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.013891569999999999	0.6932654967450945
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.013891569999999999	0.6932654967450945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.013891569999999999	0.6932654967450945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.013891569999999999	0.6932654967450945
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.013891569999999999	0.6932654967450945
LEIGH SYNDROME; LS	0.013891569999999999	0.6932654967450945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	0.6932654967450945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.013891569999999999	0.6932654967450945
ISOLATED GLYCEROL KINASE DEFICIENCY	0.01388892	0.6931332472177645
NEUROLEPTIC MALIGNANT SYNDROME	0.01388892	0.6931332472177645
HISTIOCYTOID CARDIOMYOPATHY	0.01370892	0.6841502604557125
NAVAJO NEUROHEPATOPATHY	0.01370892	0.6841502604557125
GLYCOGEN STORAGE DISEASE IB	0.01370892	0.6841502604557125
GLYCOGEN STORAGE DISEASE IA	0.01370892	0.6841502604557125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.6841502604557125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.01370892	0.6841502604557125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.01370892	0.6841502604557125
NETHERTON SYNDROME	0.013698599999999998	0.6836352358813548
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.013698599999999998	0.6836352358813548
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.013698599999999998	0.6836352358813548
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.013698599999999998	0.6836352358813548
XERODERMA PIGMENTOSUM	0.013698599999999998	0.6836352358813548
WILSON DISEASE	0.013698599999999998	0.6836352358813548
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.013698599999999998	0.6836352358813548
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.013698599999999998	0.6836352358813548
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.013698599999999998	0.6836352358813548
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.013698599999999998	0.6836352358813548
PHENYLKETONURIA	0.013698599999999998	0.6836352358813548
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.013698599999999998	0.6836352358813548
ROWLEY-ROSENBERG SYNDROME	0.013698599999999998	0.6836352358813548
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.013698599999999998	0.6836352358813548
FORMIMINOTRANSFERASE DEFICIENCY	0.013698599999999998	0.6836352358813548
BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF	0.013698599999999998	0.6836352358813548
DERMOTRICHIC SYNDROME	0.013698599999999998	0.6836352358813548
GALACTOSE EPIMERASE DEFICIENCY	0.013698599999999998	0.6836352358813548
GYRATE ATROPHY OF CHOROID AND RETINA	0.013698599999999998	0.6836352358813548
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.013698599999999998	0.6836352358813548
DENT DISEASE 1	0.013698599999999998	0.6836352358813548
STIMMLER SYNDROME	0.013698599999999998	0.6836352358813548
SIALIDOSIS TYPE 1	0.013698599999999998	0.6836352358813548
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.013698599999999998	0.6836352358813548
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.013698599999999998	0.6836352358813548
HEREDITARY OROTIC ACIDURIA	0.013698599999999998	0.6836352358813548
GALACTOSE EPIMERASE DEFICIENCY	0.013698599999999998	0.6836352358813548
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.013698599999999998	0.6836352358813548
PEELING SKIN SYNDROME	0.013698599999999998	0.6836352358813548
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.013698599999999998	0.6836352358813548
CYSTINOSIS	0.013698599999999998	0.6836352358813548
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.013698599999999998	0.6836352358813548
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0130605	0.6517905478098809
HOLOPROSENCEPHALY	0.01287785	0.6426753115204988
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01287785	0.6426753115204988
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.01219124	0.608409708516652
ANTISYNTHETASE SYNDROME	0.01209291	0.6035025024704711
CAROTENEMIA, FAMILIAL	0.0111111	0.5545048011768592
PARANA HARD-SKIN SYNDROME	0.0111111	0.5545048011768592
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.5545048011768592
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0111111	0.5545048011768592
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.5545048011768592
ACROMIAL DIMPLES	0.0111111	0.5545048011768592
SHORT SYNDROME	0.0111111	0.5545048011768592
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.0111111	0.5545048011768592
CURRY-JONES SYNDROME	0.0111111	0.5545048011768592
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.5545048011768592
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	0.5545048011768592
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.5545048011768592
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0111111	0.5545048011768592
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.5545048011768592
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.5545048011768592
DERMAL RIDGES, PATTERNLESS	0.0111111	0.5545048011768592
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.5545048011768592
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.5545048011768592
LENTIGINES	0.0111111	0.5545048011768592
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.5545048011768592
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.5545048011768592
FUTCHER LINE	0.0111111	0.5545048011768592
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.5545048011768592
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.5545048011768592
KYRLE DISEASE	0.0111111	0.5545048011768592
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.5545048011768592
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0111111	0.5545048011768592
131600 EPIDERMOID CYSTS	0.0111111	0.5545048011768592
LATERAL MENINGOCELE SYNDROME	0.0111111	0.5545048011768592
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.5545048011768592
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.5545048011768592
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.5545048011768592
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	0.5545048011768592
LICHEN PLANUS, FAMILIAL	0.0111111	0.5545048011768592
PRENATAL BOWING	0.0111111	0.5545048011768592
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.5545048011768592
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.5545048011768592
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.5545048011768592
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.5545048011768592
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.5545048011768592
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.5545048011768592
CAMOS SYNDROME	0.0111111	0.5545048011768592
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	0.5545048011768592
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.5545048011768592
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.5545048011768592
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.5545048011768592
AICARDI SYNDROME; AIC	0.0111111	0.5545048011768592
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.5545048011768592
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.5545048011768592
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.5545048011768592
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.5545048011768592
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.5545048011768592
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	0.5545048011768592
SYRINGOMAS, MULTIPLE	0.0111111	0.5545048011768592
PSEUDOATROPHODERMA COLLI	0.0111111	0.5545048011768592
PYCNODYSOSTOSIS	0.0111111	0.5545048011768592
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.5545048011768592
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.5545048011768592
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.5545048011768592
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	0.5545048011768592
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.5545048011768592
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0111111	0.5545048011768592
PIGMENTED PURPURIC ERUPTION	0.0111111	0.5545048011768592
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.5545048011768592
TRICHILEMMAL CYST 1	0.0111111	0.5545048011768592
PILONIDAL SINUS	0.0111111	0.5545048011768592
TRIOPIA	0.0111111	0.5545048011768592
GM1 GANGLIOSIDOSIS	0.0111111	0.5545048011768592
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.01051447	0.5247296934443979
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.01051447	0.5247296934443979
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.01051447	0.5247296934443979
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010416700000000001	0.5198504344681435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010416700000000001	0.5198504344681435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.010416700000000001	0.5198504344681435
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.5198504344681435
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	0.5198504344681435
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	0.5198504344681435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	0.5198504344681435
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.5198504344681435
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.5198504344681435
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010416700000000001	0.5198504344681435
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.5198504344681435
MICROVILLUS INCLUSION DISEASE	0.010416700000000001	0.5198504344681435
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.5198504344681435
ISOVALERIC ACIDEMIA	0.010416700000000001	0.5198504344681435
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.01032154	0.5151014287999387
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.01032154	0.5151014287999387
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.01032154	0.5151014287999387
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.01032154	0.5151014287999387
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.01032154	0.5151014287999387
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.01032154	0.5151014287999387
GLYCOGEN STORAGE DISEASE XI; GSD11	0.01032154	0.5151014287999387
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.01032154	0.5151014287999387
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.01032154	0.5151014287999387
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.01032154	0.5151014287999387
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.01032154	0.5151014287999387
CADASIL	0.010138890000000001	0.5059861925105567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.010138890000000001	0.5059861925105567
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.0096834	0.4832547445091843
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0096834	0.4832547445091843
DYSTROPHIA MYOTONICA 2	0.0096834	0.4832547445091843
LIPEDEMA	0.00862069	0.4302196897208501
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.00862069	0.4302196897208501
MAJEED SYNDROME	0.00862069	0.4302196897208501
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00862069	0.4302196897208501
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00862069	0.4302196897208501
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00862069	0.4302196897208501
WHITE SPONGE NEVUS 2; WSN2	0.00862069	0.4302196897208501
RETINITIS PIGMENTOSA 71; RP71	0.00862069	0.4302196897208501
DISSECTING CELLULITIS OF THE SCALP	0.00862069	0.4302196897208501
ENHANCED S-CONE SYNDROME	0.00862069	0.4302196897208501
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.00862069	0.4302196897208501
NK-CELL ENTEROPATHY	0.00862069	0.4302196897208501
DERMATITIS HERPETIFORMIS	0.00862069	0.4302196897208501
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00862069	0.4302196897208501
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00862069	0.4302196897208501
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00862069	0.4302196897208501
EOSINOPHILIC GASTROENTERITIS	0.00862069	0.4302196897208501
BAZEX SYNDROME	0.00862069	0.4302196897208501
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.00862069	0.4302196897208501
KAWASAKI DISEASE	0.00862069	0.4302196897208501
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00862069	0.4302196897208501
NOONAN SYNDROME 6; NS6	0.00862069	0.4302196897208501
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00862069	0.4302196897208501
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.00862069	0.4302196897208501
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00862069	0.4302196897208501
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.00862069	0.4302196897208501
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00862069	0.4302196897208501
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00862069	0.4302196897208501
ANEURYSM OF SINUS OF VALSALVA	0.00862069	0.4302196897208501
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00862069	0.4302196897208501
PORPHYRIA CUTANEA TARDA	0.00862069	0.4302196897208501
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00862069	0.4302196897208501
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.00862069	0.4302196897208501
PAPILLORENAL SYNDROME	0.00862069	0.4302196897208501
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.00862069	0.4302196897208501
CLUSTER HEADACHE, FAMILIAL	0.00862069	0.4302196897208501
SEA-BLUE HISTIOCYTOSIS	0.00862069	0.4302196897208501
ILEAL NEUROENDOCRINE TUMOR	0.00862069	0.4302196897208501
JEJUNAL NEUROENDOCRINE TUMOR	0.00862069	0.4302196897208501
DUODENAL NEUROENDOCRINE TUMOR	0.00862069	0.4302196897208501
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.00862069	0.4302196897208501
CHÉDIAK-HIGASHI SYNDROME	0.00862069	0.4302196897208501
THORACIC OUTLET SYNDROME	0.00862069	0.4302196897208501
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00862069	0.4302196897208501
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00862069	0.4302196897208501
%152800 LYMPHANGIECTASIA, INTESTINAL	0.00862069	0.4302196897208501
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00862069	0.4302196897208501
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00862069	0.4302196897208501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00862069	0.4302196897208501
OMENN SYNDROME	0.00862069	0.4302196897208501
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00862069	0.4302196897208501
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00862069	0.4302196897208501
EOSINOPHILIC ESOPHAGITIS	0.00862069	0.4302196897208501
CREST SYNDROME	0.00862069	0.4302196897208501
WELLS SYNDROME	0.00862069	0.4302196897208501
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00862069	0.4302196897208501
PEHO-LIKE SYNDROME; PEHOL	0.00862069	0.4302196897208501
PIERSON SYNDROME	0.00862069	0.4302196897208501
MASTOCYTOSIS, CUTANEOUS; MASTC	0.00862069	0.4302196897208501
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00862069	0.4302196897208501
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00862069	0.4302196897208501
SYSTEMIC SCLEROSIS	0.00862069	0.4302196897208501
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00862069	0.4302196897208501
PLAGUE	0.00862069	0.4302196897208501
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00862069	0.4302196897208501
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00862069	0.4302196897208501
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00862069	0.4302196897208501
CHILBLAIN LUPUS 2; CHBL2	0.00862069	0.4302196897208501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00862069	0.4302196897208501
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00862069	0.4302196897208501
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00862069	0.4302196897208501
GLYCOGEN STORAGE DISEASE IV	0.00862069	0.4302196897208501
RETINAL VENOUS BEADING	0.00862069	0.4302196897208501
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00862069	0.4302196897208501
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00862069	0.4302196897208501
OPSISMODYSPLASIA; OPSMD	0.00862069	0.4302196897208501
SAPHO SYNDROME	0.00862069	0.4302196897208501
THYMIC EPITHELIAL NEOPLASM	0.00862069	0.4302196897208501
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00862069	0.4302196897208501
PREECLAMPSIA/ECLAMPSIA 1	0.00862069	0.4302196897208501
SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS	0.00862069	0.4302196897208501
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.00862069	0.4302196897208501
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00862069	0.4302196897208501
EBSTEIN MALFORMATION	0.00840336	0.4193737313153127
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.4193737313153127
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.4193737313153127
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.4193737313153127
KAGAMI-OGATA SYNDROME	0.00840336	0.4193737313153127
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.4193737313153127
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.4193737313153127
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.4193737313153127
INFANTILE SIALIC ACID STORAGE DISEASE	0.00840336	0.4193737313153127
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.4193737313153127
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.4193737313153127
TEMPLE SYNDROME	0.00840336	0.4193737313153127
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00840336	0.4193737313153127
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.4193737313153127
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.4193737313153127
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.4193737313153127
RENAL TUBULAR DYSGENESIS	0.00840336	0.4193737313153127
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00840336	0.4193737313153127
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.4193737313153127
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.4193737313153127
DISTAL MONOSOMY 17Q	0.00840336	0.4193737313153127
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.4193737313153127
NEMALINE MYOPATHY 10	0.00840336	0.4193737313153127
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.4193737313153127
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.4193737313153127
TYSHCHENKO SYNDROME	0.00840336	0.4193737313153127
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.4193737313153127
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.4193737313153127
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.4193737313153127
JACOBSEN SYNDROME	0.00840336	0.4193737313153127
ZELLWEGER SYNDROME	0.00840336	0.4193737313153127
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.4193737313153127
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.4193737313153127
GALLOWAY-MOWAT SYNDROME	0.00840336	0.4193737313153127
CONGENITAL TOXOPLASMOSIS	0.00840336	0.4193737313153127
FG SYNDROME TYPE 1	0.00840336	0.4193737313153127
SCHISIS ASSOCIATION	0.00840336	0.4193737313153127
GMS SYNDROME	0.00840336	0.4193737313153127
PEMPHIGOID GESTATIONIS	0.00840336	0.4193737313153127
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00840336	0.4193737313153127
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00840336	0.4193737313153127
VACTERL/VATER ASSOCIATION	0.00840336	0.4193737313153127
HEC SYNDROME	0.00840336	0.4193737313153127
HYDROLETHALUS	0.00840336	0.4193737313153127
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.4193737313153127
ROBERTS SYNDROME	0.00840336	0.4193737313153127
KAGAMI-OGATA SYNDROME	0.00840336	0.4193737313153127
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00840336	0.4193737313153127
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.4193737313153127
RETINOPATHY OF PREMATURITY	0.00840336	0.4193737313153127
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.4193737313153127
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.4193737313153127
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.4193737313153127
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.4193737313153127
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.4193737313153127
ADAMS-OLIVER SYNDROME	0.00840336	0.4193737313153127
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.4193737313153127
YUNIS-VARON SYNDROME	0.00840336	0.4193737313153127
ROIFMAN SYNDROME; RFMN	0.00840336	0.4193737313153127
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00840336	0.4193737313153127
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00840336	0.4193737313153127
CARDIOFACIOCUTANEOUS SYNDROME	0.00840336	0.4193737313153127
CORNELIA DE LANGE SYNDROME	0.00840336	0.4193737313153127
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.4193737313153127
OMPHALOCELE	0.00840336	0.4193737313153127
VASCULAR EHLERS-DANLOS SYNDROME	0.00840336	0.4193737313153127
FATCO SYNDROME	0.00840336	0.4193737313153127
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.4193737313153127
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.4193737313153127
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.4193737313153127
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.4193737313153127
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.4193737313153127
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.4193737313153127
GAUCHER DISEASE, PERINATAL LETHAL	0.00840336	0.4193737313153127
DISTAL MONOSOMY 10Q	0.00840336	0.4193737313153127
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00840336	0.4193737313153127
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.4193737313153127
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.4193737313153127
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.4193737313153127
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.4193737313153127
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.4193737313153127
MYOPATHY, SPHEROID BODY	0.0072601	0.3623187899509603
GRACILE SYNDROME	0.00704225	0.3514468806947769
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00704225	0.3514468806947769
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00704225	0.3514468806947769
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.3514468806947769
3-HYDROXYISOBUTYRIC ACIDURIA	0.00704225	0.3514468806947769
INFANTILE LIVER FAILURE SYNDROME 1	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00704225	0.3514468806947769
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.00704225	0.3514468806947769
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.00704225	0.3514468806947769
PSEUDO-TORCH SYNDROME 2	0.00704225	0.3514468806947769
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.3514468806947769
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00704225	0.3514468806947769
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.3514468806947769
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.3514468806947769
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00704225	0.3514468806947769
SUCCINIC ACIDEMIA	0.00704225	0.3514468806947769
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00704225	0.3514468806947769
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.3514468806947769
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00704225	0.3514468806947769
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.3514468806947769
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.00704225	0.3514468806947769
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.3514468806947769
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00704225	0.3514468806947769
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00684932	0.34181861605031766
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.34181861605031766
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.34181861605031766
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00684932	0.34181861605031766
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00684932	0.34181861605031766
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00684932	0.34181861605031766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00684932	0.34181861605031766
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00684932	0.34181861605031766
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00684932	0.34181861605031766
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00684932	0.34181861605031766
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00684932	0.34181861605031766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00684932	0.34181861605031766
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00684932	0.34181861605031766
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00684932	0.34181861605031766
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00684932	0.34181861605031766
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.34181861605031766
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.34181861605031766
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00684932	0.34181861605031766
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.34181861605031766
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00684932	0.34181861605031766
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00684932	0.34181861605031766
SALT-AND-PEPPER SYNDROME	0.00684932	0.34181861605031766
AMISH INFANTILE EPILEPSY SYNDROME	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00684932	0.34181861605031766
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00684932	0.34181861605031766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00684932	0.34181861605031766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.34181861605031766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00684932	0.34181861605031766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.34181861605031766
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.34181861605031766
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.00684932	0.34181861605031766
TENORIO SYNDROME; TNORS	0.00666667	0.33270337976093556
MENKES DISEASE	0.00666667	0.33270337976093556
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	0.33270337976093556
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.33270337976093556
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.33270337976093556
LARON SYNDROME	0.00666667	0.33270337976093556
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.33270337976093556
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.33270337976093556
SOTOS SYNDROME	0.00666667	0.33270337976093556
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.00666667	0.33270337976093556
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.33270337976093556
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.33270337976093556
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	0.33270337976093556
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.33270337976093556
TIMOTHY SYNDROME; TS	0.00666667	0.33270337976093556
GALACTOSEMIA	0.00666667	0.33270337976093556
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.33270337976093556
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00666667	0.33270337976093556
OCULODENTODIGITAL DYSPLASIA	0.00666667	0.33270337976093556
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	0.33270337976093556
NEONATAL HEMOCHROMATOSIS	0.00666667	0.33270337976093556
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.33270337976093556
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.00666667	0.33270337976093556
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	0.33270337976093556
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	0.33270337976093556
LEPRECHAUNISM	0.00666667	0.33270337976093556
MEHMO SYNDROME; MEHMO	0.00666667	0.33270337976093556
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	0.33270337976093556
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.33270337976093556
MPI-CDG	0.00666667	0.33270337976093556
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00666667	0.33270337976093556
COG8-CDG	0.00666667	0.33270337976093556
PANHYPOPITUITARISM	0.00666667	0.33270337976093556
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.33270337976093556
CLASSIC GALACTOSEMIA	0.00666667	0.33270337976093556
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.33270337976093556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00666667	0.33270337976093556
PITUITARY STALK INTERRUPTION SYNDROME	0.00666667	0.33270337976093556
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	0.33270337976093556
SHASHI-PENA SYNDROME; SHAPNS	0.00666667	0.33270337976093556
MIRAGE SYNDROME; MIRAGE	0.00666667	0.33270337976093556
SHEEHAN SYNDROME	0.00666667	0.33270337976093556
HEPATOCELLULAR CARCINOMA	0.00666667	0.33270337976093556
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00666667	0.33270337976093556
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	0.33270337976093556
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00666667	0.33270337976093556
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.33270337976093556
ENDOCARDIAL FIBROELASTOSIS	0.00666667	0.33270337976093556
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	0.33270337976093556
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.33270337976093556
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.33270337976093556
PITUITARY APOPLEXY	0.00666667	0.33270337976093556
HYPOADRENOCORTICISM, FAMILIAL	0.00666667	0.33270337976093556
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	0.33270337976093556
HOLOPROSENCEPHALY 1; HPE1	0.00666667	0.33270337976093556
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE VI	0.00666667	0.33270337976093556
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.33270337976093556
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.33270337976093556
CONGENITAL DISORDER OF GLYCOSYLATION	0.00666667	0.33270337976093556
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	0.33270337976093556
SMITH-KINGSMORE SYNDROME; SKS	0.00666667	0.33270337976093556
VIPOMA	0.00621118	0.3099719317595633
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.00621118	0.3099719317595633
WOODHOUSE-SAKATI SYNDROME	0.00621118	0.3099719317595633
WOLFRAM SYNDROME	0.00621118	0.3099719317595633
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00621118	0.3099719317595633
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00621118	0.3099719317595633
GLUCAGONOMA	0.00621118	0.3099719317595633
ACROMEGALY	0.00621118	0.3099719317595633
CUSHING DISEASE	0.00621118	0.3099719317595633
HYPERLIPOPROTEINEMIA, TYPE V	0.00621118	0.3099719317595633
SOMATOSTATINOMA	0.00621118	0.3099719317595633
DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.00621118	0.3099719317595633
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00621118	0.3099719317595633
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00621118	0.3099719317595633
RAMON SYNDROME	0.00621118	0.3099719317595633
RCAD (RENAL CYSTS AND DIABETES)	0.00621118	0.3099719317595633
SOMATOMAMMOTROPINOMA	0.00621118	0.3099719317595633
12Q14 MICRODELETION SYNDROME	0.00621118	0.3099719317595633
ACTH-INDEPENDENT CUSHING SYNDROME	0.00621118	0.3099719317595633
BARDET-BIEDL SYNDROME 6; BBS6	0.00621118	0.3099719317595633
WOLFRAM SYNDROME 2; WFS2	0.00621118	0.3099719317595633
SHORT SYNDROME	0.00621118	0.3099719317595633
ACERULOPLASMINEMIA	0.00621118	0.3099719317595633
ACTH-DEPENDENT CUSHING SYNDROME	0.00621118	0.3099719317595633
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00621118	0.3099719317595633
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00621118	0.3099719317595633
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00621118	0.3099719317595633
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00621118	0.3099719317595633
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00621118	0.3099719317595633
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00621118	0.3099719317595633
RENPENNING SYNDROME	0.00621118	0.3099719317595633
DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.00621118	0.3099719317595633
DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.00621118	0.3099719317595633
PREAXIAL HALLUCAL POLYDACTYLY	0.00621118	0.3099719317595633
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00621118	0.3099719317595633
%601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15;;INSULIN-DEPENDENT DIABETES MELLITUS 15	0.00621118	0.3099719317595633
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00621118	0.3099719317595633
DYSBETALIPOPROTEINEMIA	0.00621118	0.3099719317595633
ATAXIA WITH VITAMIN E DEFICIENCY	0.00621118	0.3099719317595633
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00621118	0.3099719317595633
BARDET-BIEDL SYNDROME 1; BBS1	0.00621118	0.3099719317595633
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.00621118	0.3099719317595633
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00621118	0.3099719317595633
CRANIAL NERVES, RECURRENT PARESIS OF	0.00621118	0.3099719317595633
AICARDI-GOUTIÈRES SYNDROME	0.00621118	0.3099719317595633
HEMOCHROMATOSIS TYPE 2	0.00621118	0.3099719317595633
PRIMROSE SYNDROME; PRIMS	0.00621118	0.3099719317595633
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00621118	0.3099719317595633
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00621118	0.3099719317595633
CUSHING SYNDROME	0.00621118	0.3099719317595633
PERIPARTUM CARDIOMYOPATHY	0.00621118	0.3099719317595633
ALEXANDER DISEASE	0.00621118	0.3099719317595633
NORRIE DISEASE	0.00621118	0.3099719317595633
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00621118	0.3099719317595633
HEREDITARY CHRONIC PANCREATITIS	0.00621118	0.3099719317595633
BULLOUS PEMPHIGOID	0.00621118	0.3099719317595633
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00621118	0.3099719317595633
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00621118	0.3099719317595633
ACERULOPLASMINEMIA	0.00621118	0.3099719317595633
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00621118	0.3099719317595633
167755 PANCREAS, DORSAL, AGENESIS OF	0.00621118	0.3099719317595633
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00621118	0.3099719317595633
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00621118	0.3099719317595633
WOLFRAM-LIKE SYNDROME	0.00621118	0.3099719317595633
FRIEDREICH ATAXIA	0.00621118	0.3099719317595633
WERNER SYNDROME; WRN	0.00621118	0.3099719317595633
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00621118	0.3099719317595633
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00621118	0.3099719317595633
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00621118	0.3099719317595633
MEHMO SYNDROME	0.00621118	0.3099719317595633
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00621118	0.3099719317595633
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.00621118	0.3099719317595633
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00621118	0.3099719317595633
STIFF-PERSON SYNDROME; SPS	0.00621118	0.3099719317595633
EPIDERMOLYSIS BULLOSA ACQUISITA	0.00621118	0.3099719317595633
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00621118	0.3099719317595633
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00621118	0.3099719317595633
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00621118	0.3099719317595633
DYSKERATOSIS CONGENITA	0.00621118	0.3099719317595633
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00621118	0.3099719317595633
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00621118	0.3099719317595633
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00621118	0.3099719317595633
NEUROTROPHIC KERATOPATHY	0.00621118	0.3099719317595633
FAMILIAL PANCREATIC CARCINOMA	0.00621118	0.3099719317595633
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00621118	0.3099719317595633
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00621118	0.3099719317595633
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00621118	0.3099719317595633
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00621118	0.3099719317595633
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00621118	0.3099719317595633
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00621118	0.3099719317595633
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00621118	0.3099719317595633
BARDET-BIEDL SYNDROME 2	0.00621118	0.3099719317595633
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00621118	0.3099719317595633
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00621118	0.3099719317595633
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.00621118	0.3099719317595633
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00621118	0.3099719317595633
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00621118	0.3099719317595633
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	0.00621118	0.3099719317595633
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00621118	0.3099719317595633
BETA-THALASSEMIA INTERMEDIA	0.00621118	0.3099719317595633
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00621118	0.3099719317595633
BETA-THALASSEMIA MAJOR	0.00621118	0.3099719317595633
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00621118	0.3099719317595633
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00621118	0.3099719317595633
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00621118	0.3099719317595633
GOOD SYNDROME	0.00621118	0.3099719317595633
AFRICAN IRON OVERLOAD	0.00621118	0.3099719317595633
PAROXYSMAL HEMICRANIA	0.00621118	0.3099719317595633
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00621118	0.3099719317595633
H SYNDROME	0.00621118	0.3099719317595633
17Q12 MICRODELETION SYNDROME	0.00621118	0.3099719317595633
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00621118	0.3099719317595633
GAPO SYNDROME; GAPOS	0.00378788	0.1890359772013393
REVESZ SYNDROME	0.00378788	0.1890359772013393
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1890359772013393
LYMPHOKINE DEFICIENCY	0.00378788	0.1890359772013393
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1890359772013393
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1890359772013393
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1890359772013393
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	0.1890359772013393
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1890359772013393
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1890359772013393
46,XX GONADAL DYSGENESIS	0.00378788	0.1890359772013393
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1890359772013393
ACETYLATION, SLOW	0.00378788	0.1890359772013393
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00378788	0.1890359772013393
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1890359772013393
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1890359772013393
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00378788	0.1890359772013393
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00378788	0.1890359772013393
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.1890359772013393
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.1890359772013393
HYPOASCORBEMIA	0.00378788	0.1890359772013393
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1890359772013393
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1890359772013393
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.1890359772013393
REFSUM DISEASE	0.00378788	0.1890359772013393
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1890359772013393
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1890359772013393
GLUTATHIONURIA	0.00378788	0.1890359772013393
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1890359772013393
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1890359772013393
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.1890359772013393
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1890359772013393
OSTEOGENIC SARCOMA	0.00378788	0.1890359772013393
LARON SYNDROME	0.00378788	0.1890359772013393
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.1890359772013393
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1890359772013393
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1890359772013393
PITUITARY DWARFISM IV	0.00378788	0.1890359772013393
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1890359772013393
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1890359772013393
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1890359772013393
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1890359772013393
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1890359772013393
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1890359772013393
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.00378788	0.1890359772013393
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00378788	0.1890359772013393
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.1890359772013393
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1890359772013393
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1890359772013393
ETHANOLAMINOSIS	0.00378788	0.1890359772013393
NEPHROSIALIDOSIS	0.00378788	0.1890359772013393
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.1890359772013393
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1890359772013393
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.1890359772013393
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1890359772013393
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1890359772013393
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1890359772013393
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1890359772013393
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1890359772013393
PROGESTERONE RESISTANCE	0.00378788	0.1890359772013393
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1890359772013393
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1890359772013393
PYRIDOXINE-DEPENDENT EPILEPSY	0.00378788	0.1890359772013393
EPILEPSY-TELANGIECTASIA	0.00378788	0.1890359772013393
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.1890359772013393
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1890359772013393
BARTTER SYNDROME	0.00378788	0.1890359772013393
APOLIPOPROTEIN(A)	0.00378788	0.1890359772013393
CUTIS LAXA	0.00378788	0.1890359772013393
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1890359772013393
OVARIAN CANCER	0.00378788	0.1890359772013393
PACMAN DYSPLASIA	0.00378788	0.1890359772013393
PERRY SYNDROME	0.00378788	0.1890359772013393
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1890359772013393
PARAOXONASE 1	0.00378788	0.1890359772013393
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.1890359772013393
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1890359772013393
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.1890359772013393
NEURONAL CEROID LIPOFUSCINOSIS	0.00378788	0.1890359772013393
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1890359772013393
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1890359772013393
HYPERPROGLUCAGONEMIA	0.00378788	0.1890359772013393
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1890359772013393
HEINZ BODY ANEMIAS	0.00378788	0.1890359772013393
GLUTATHIONE REDUCTASE	0.00378788	0.1890359772013393
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1890359772013393
BEETURIA	0.00378788	0.1890359772013393
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1890359772013393
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.1890359772013393
CARBOXYLESTERASE 1	0.00378788	0.1890359772013393
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1890359772013393
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1890359772013393
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1890359772013393
COUMARIN RESISTANCE	0.00378788	0.1890359772013393
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1890359772013393
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1890359772013393
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1890359772013393
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1890359772013393
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1890359772013393
FLOOD FACTOR DEFICIENCY	0.00378788	0.1890359772013393
SPINAL ARACHNOIDITIS	0.00378788	0.1890359772013393
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1890359772013393
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1890359772013393
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1890359772013393
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.1890359772013393
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1890359772013393
CEPHALIN LIPIDOSIS	0.00378788	0.1890359772013393
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.1890359772013393
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.00378788	0.1890359772013393
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.1890359772013393
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1890359772013393
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1890359772013393
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1890359772013393
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.1890359772013393
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1890359772013393
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1890359772013393
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1890359772013393
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	0.1890359772013393
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.1890359772013393
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	0.1890359772013393
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.1890359772013393
ASPARTYLGLUCOSAMINURIA; AGU	0.00378788	0.1890359772013393
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	0.1890359772013393
AREDYLD	0.00378788	0.1890359772013393
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1890359772013393
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.1890359772013393
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1890359772013393
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1890359772013393
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1890359772013393
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1890359772013393
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1890359772013393
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1890359772013393
ZINC, ELEVATED PLASMA	0.00378788	0.1890359772013393
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1890359772013393
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.1890359772013393
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1890359772013393
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1890359772013393
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.1890359772013393
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1890359772013393
DERMATOLEUKODYSTROPHY	0.00378788	0.1890359772013393
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00378788	0.1890359772013393
DELETED IN AZOOSPERMIA	0.00378788	0.1890359772013393
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1890359772013393
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.1890359772013393
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.1890359772013393
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	0.1890359772013393
MACROCYTOSIS, FAMILIAL	0.00378788	0.1890359772013393
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1890359772013393
ONCOCYTOMA	0.00378788	0.1890359772013393
GONADOBLASTOMA	0.00378788	0.1890359772013393
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.1890359772013393
XM SYSTEM	0.00378788	0.1890359772013393
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1890359772013393
OSTEOMESOPYKNOSIS	0.00378788	0.1890359772013393
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1890359772013393
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.1890359772013393
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.00378788	0.1890359772013393
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1890359772013393
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1890359772013393
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.1890359772013393
ICHTHYOSIS, X-LINKED	0.00378788	0.1890359772013393
GRANULOMAS, CONGENITAL CEREBRAL	0.00378788	0.1890359772013393
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.1890359772013393
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1890359772013393
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1890359772013393
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1890359772013393
CALVARIAL HYPEROSTOSIS	0.00378788	0.1890359772013393
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.1890359772013393
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	0.1890359772013393
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1890359772013393
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1890359772013393
ALAND ISLAND EYE DISEASE	0.00378788	0.1890359772013393
DERMATITIS, ATOPIC	0.00378788	0.1890359772013393
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.1890359772013393
LARSEN-LIKE SYNDROME	0.00378788	0.1890359772013393
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.1890359772013393
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1890359772013393
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00378788	0.1890359772013393
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.1890359772013393
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00378788	0.1890359772013393
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.1890359772013393
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00378788	0.1890359772013393
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1890359772013393
EMANUEL SYNDROME	0.00378788	0.1890359772013393
SALLA DISEASE	0.00378788	0.1890359772013393
CHROMOSOME 10Q26 DELETION SYNDROME	0.00378788	0.1890359772013393
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1890359772013393
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1890359772013393
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.1890359772013393
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1890359772013393
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1890359772013393
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1890359772013393
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1890359772013393
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1890359772013393
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.1890359772013393
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1890359772013393
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1890359772013393
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.1890359772013393
SCHIZOPHRENIA 4	0.00378788	0.1890359772013393
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00378788	0.1890359772013393
FINGERPRINT BODY MYOPATHY	0.00378788	0.1890359772013393
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.1890359772013393
XANTHINURIA, TYPE I	0.00378788	0.1890359772013393
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1890359772013393
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1890359772013393
PENDRED SYNDROME	0.00378788	0.1890359772013393
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00378788	0.1890359772013393
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.1890359772013393
NEONATAL ADRENOLEUKODYSTROPHY	0.00378788	0.1890359772013393
T-SUBSTANCE ANOMALY	0.00378788	0.1890359772013393
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1890359772013393
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.1890359772013393
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.1890359772013393
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1890359772013393
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.1890359772013393
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00378788	0.1890359772013393
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.1890359772013393
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.1890359772013393
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.1890359772013393
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1890359772013393
XYLOSIDASE DEFICIENCY	0.00378788	0.1890359772013393
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.1890359772013393
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00347222	0.17328281274962098
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00347222	0.17328281274962098
MYOPATHY, DISTAL, INFANTILE-ONSET	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00347222	0.17328281274962098
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00347222	0.17328281274962098
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00347222	0.17328281274962098
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.00347222	0.17328281274962098
EPISODIC ATAXIA, TYPE 1; EA1	0.00347222	0.17328281274962098
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00347222	0.17328281274962098
JUVENILE DERMATOMYOSITIS	0.00347222	0.17328281274962098
BETHLEM MYOPATHY 1	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00347222	0.17328281274962098
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.00347222	0.17328281274962098
SALIH MYOPATHY; SALMY	0.00347222	0.17328281274962098
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00347222	0.17328281274962098
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00347222	0.17328281274962098
STORMORKEN SYNDROME; STRMK	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00347222	0.17328281274962098
TETANUS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.00347222	0.17328281274962098
LISSENCEPHALY 8; LIS8	0.00347222	0.17328281274962098
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00347222	0.17328281274962098
WILLIAMS SYNDROME	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.00347222	0.17328281274962098
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00347222	0.17328281274962098
MUSCLE CRAMPS, FAMILIAL	0.00347222	0.17328281274962098
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00347222	0.17328281274962098
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00347222	0.17328281274962098
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00347222	0.17328281274962098
BECKER MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
DUCHENNE MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00347222	0.17328281274962098
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00347222	0.17328281274962098
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00347222	0.17328281274962098
DISTAL MYOTILINOPATHY	0.00347222	0.17328281274962098
XQ12-Q13.3 DUPLICATION SYNDROME	0.00347222	0.17328281274962098
RIPPLING MUSCLE DISEASE; RMD	0.00347222	0.17328281274962098
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00347222	0.17328281274962098
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.00347222	0.17328281274962098
MYOTONIA FLUCTUANS	0.00347222	0.17328281274962098
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00347222	0.17328281274962098
MYOTONIA, POTASSIUM-AGGRAVATED	0.00347222	0.17328281274962098
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.00347222	0.17328281274962098
AXIAL OSTEOMALACIA	0.00347222	0.17328281274962098
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00347222	0.17328281274962098
TYPICAL NEMALINE MYOPATHY	0.00347222	0.17328281274962098
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00347222	0.17328281274962098
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00347222	0.17328281274962098
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00347222	0.17328281274962098
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.00347222	0.17328281274962098
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00347222	0.17328281274962098
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00347222	0.17328281274962098
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00347222	0.17328281274962098
MYOTILINOPATHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00347222	0.17328281274962098
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00347222	0.17328281274962098
NONAKA MYOPATHY	0.00347222	0.17328281274962098
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00347222	0.17328281274962098
FOCAL MYOSITIS	0.00347222	0.17328281274962098
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.00347222	0.17328281274962098
ZEBRA BODY MYOPATHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00347222	0.17328281274962098
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.00347222	0.17328281274962098
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00347222	0.17328281274962098
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00347222	0.17328281274962098
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00347222	0.17328281274962098
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00347222	0.17328281274962098
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.00347222	0.17328281274962098
HYPERKALEMIC PERIODIC PARALYSIS	0.00347222	0.17328281274962098
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.00347222	0.17328281274962098
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00347222	0.17328281274962098
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00347222	0.17328281274962098
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00347222	0.17328281274962098
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00347222	0.17328281274962098
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00347222	0.17328281274962098
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00347222	0.17328281274962098
CHOREOACANTHOCYTOSIS	0.00347222	0.17328281274962098
BETHLEM MYOPATHY 2; BTHLM2	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00347222	0.17328281274962098
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.00347222	0.17328281274962098
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00347222	0.17328281274962098
POLYMYOSITIS	0.00347222	0.17328281274962098
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00347222	0.17328281274962098
MUSCLE-EYE-BRAIN DISEASE	0.00347222	0.17328281274962098
MARINESCO-SJOGREN SYNDROME; MSS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00347222	0.17328281274962098
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00347222	0.17328281274962098
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.00347222	0.17328281274962098
INCLUSION BODY MYOSITIS	0.00347222	0.17328281274962098
POTASSIUM-AGGRAVATED MYOTONIA	0.00347222	0.17328281274962098
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00347222	0.17328281274962098
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00347222	0.17328281274962098
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00347222	0.17328281274962098
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.00347222	0.17328281274962098
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00347222	0.17328281274962098
MCLEOD SYNDROME; MCLDS	0.00347222	0.17328281274962098
FACIOSCAPULOHUMERAL DYSTROPHY	0.00347222	0.17328281274962098
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00347222	0.17328281274962098
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00347222	0.17328281274962098
CENTRAL CORE DISEASE	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE V; GSD5	0.00347222	0.17328281274962098
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00347222	0.17328281274962098
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.00347222	0.17328281274962098
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00347222	0.17328281274962098
SCHWARTZ-JAMPEL SYNDROME	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00347222	0.17328281274962098
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00347222	0.17328281274962098
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00347222	0.17328281274962098
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.00347222	0.17328281274962098
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE II	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00347222	0.17328281274962098
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.00347222	0.17328281274962098
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00347222	0.17328281274962098
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00347222	0.17328281274962098
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00347222	0.17328281274962098
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00347222	0.17328281274962098
MUSCLE GLYCOGENOSIS, X-LINKED	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00347222	0.17328281274962098
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00347222	0.17328281274962098
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00347222	0.17328281274962098
CRAMPS, FAMILIAL ADOLESCENT	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00347222	0.17328281274962098
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00347222	0.17328281274962098
COWCHOCK SYNDROME; COWCK	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00347222	0.17328281274962098
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00347222	0.17328281274962098
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00347222	0.17328281274962098
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.00347222	0.17328281274962098
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00347222	0.17328281274962098
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.00347222	0.17328281274962098
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00347222	0.17328281274962098
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00347222	0.17328281274962098
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00347222	0.17328281274962098
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00347222	0.17328281274962098
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00347222	0.17328281274962098
